Most Pivotal Trials of New Drugs Recruit From Low-, Middle-Income Countries
MONDAY, Nov. 21, 2022 (HealthDay News) -- Most pivotal trials of new cancer, cardiovascular, and neurologic drugs recruit from low- and middle-income countries (LMIC), according to…